
Biopharmaceutical manufacturing is undergoing a transformation, driven by the need for increased efficiency, higher yield, and improved product quality. One of the most pressing challenges in this industry is managing raw material variability, which significantly impacts production outcomes, batch consistency, and regulatory compliance. Traditional approaches to raw material control rely heavily on manual processes, siloed data, and reactive decision-making, leading to inefficiencies and deviations that can delay production and increase costs.
In this webinar, we explore how AI-driven solutions are revolutionizing raw material management in biomanufacturing, using a real-world case study from a top 10 biopharma company. By implementing Katalyze AI’s Raw Material Analytics Platform, this global leader digitized and analyzed 100% of unstructured raw material data, automated monitoring of critical raw material attributes, and leveraged predictive AI models to optimize yield and quality. Within just 10 weeks, the company achieved a 5% yield improvement, reduced cycle times, and unlocked $10M+ in annualized impact per site—a testament to the power of AI in transforming biomanufacturing.
By the end of this webinar, attendees will gain a clear understanding of how AI can be a strategic enabler for improving yield, reducing deviations, and scaling biomanufacturing operations. We will provide actionable insights on implementing AI in raw material control, ensuring quality consistency, and driving cost efficiencies across production sites.